Published in Radiother Oncol on April 01, 1985
Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response. Br J Cancer (1995) 0.89
Growth and radiosensitivity testing of human tumour cells using the adhesive tumour cell culture system. Br J Cancer (1990) 0.89
High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line. Br J Cancer (1989) 0.89
Micronucleus formation in human tumour cells: lack of correlation with radiosensitivity. Br J Cancer (1993) 0.88
Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours. Br J Cancer (1989) 0.83
Host cell reactivation of gamma-irradiated adenovirus 5 in human cell lines of varying radiosensitivity. Br J Cancer (1992) 0.79
Targeted radiotherapy for neuroblastoma. Arch Dis Child (1997) 0.76
Combined management of malignant teratoma of the testis. Lancet (1979) 3.12
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77
Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys (1979) 2.63
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Measuring community hospital service in Michigan. Health Serv Res (1981) 1.97
Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol (1983) 1.87
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84
Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer (1978) 1.77
The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol (1984) 1.68
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (1982) 1.58
The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer (1983) 1.53
Emission and transmission brain tomography. Br Med J (1980) 1.46
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46
The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl (1980) 1.44
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer (1977) 1.43
A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis. Development (1997) 1.43
Basal cell carcinoma at the site of a nasal piercing. J Plast Reconstr Aesthet Surg (2008) 1.39
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer (1991) 1.39
Temperature data from satellite imagery and the distribution of schistosomiasis in Egypt. Am J Trop Med Hyg (1994) 1.34
Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.33
High frequency of aberrant p16(INK4A) expression in human breast cancer. Am J Pathol (1996) 1.32
Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. Br J Cancer (1980) 1.31
In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res (1978) 1.31
Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. Br J Cancer (1979) 1.30
The role of computed tomography in the management of testicular teratoma. Clin Radiol (1979) 1.28
Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer (1984) 1.25
Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer (1985) 1.24
Influence of tumour size on radiosensitization by misonidazole. Br J Cancer Suppl (1978) 1.24
Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group. Br J Cancer (1994) 1.22
Testicular tumours. Clin Endocrinol Metab (1975) 1.20
Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer (1980) 1.20
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer (1979) 1.19
Does race affect hospital use? Am J Public Health (1985) 1.17
Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer (1973) 1.17
Children fathered by men treated for testicular cancer. Lancet (1985) 1.16
Etoposide as a single agent in relapsed advanced lymphomas. A phase II study. Cancer Chemother Pharmacol (1982) 1.15
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol (1989) 1.14
Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer (1969) 1.14
The effect on dipyridamole on platelet aggregation and adhesiveness. Scott Med J (1968) 1.14
Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol (1989) 1.13
Preservation of ovarian function in patients requiring radiotherapy for para-aortic and pelvic Hodgkin's disease. Lancet (1972) 1.13
VP16-213 as a single agent in advanced testicular tumors. Eur J Cancer (1980) 1.13
Combination chemotherapy for testicular tumours. Proc R Soc Med (1974) 1.13
The management of metastatic seminoma testis. Cancer (1982) 1.12
The dose-rate effect in human tumour cells. Radiother Oncol (1987) 1.10
Radiation therapy of the non-Hodgkin's lymphomas. Semin Hematol (1974) 1.09
The response of lymph node metastases of testicular teratoma to radiation therapy. Br J Urol (1976) 1.09
Human tumour xenografts: a critical appraisal. Br J Cancer Suppl (1980) 1.08
Radiosensitivity of the acute leukaemic infiltrate. Eur J Cancer (1976) 1.06
The results of radiotherapy for Hodgkins' disease. Br J Cancer (1975) 1.06
Research and ophthalmology in the UK. Lancet (1990) 1.06
Cell intercalation during notochord development in Xenopus laevis. J Exp Zool (1989) 1.05
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. Br J Cancer (1980) 1.05
Combined radiotherapy--chemotherapy of Lewis lung carcinoma. Int J Radiat Oncol Biol Phys (1978) 1.04
Occult germ-cell testicular tumours. Br J Urol (1983) 1.04
Is there a future for single photon emission tomography? Rofo (1979) 1.03
A new transverse-section brain imager for single-gamma emitters. J Nucl Med (1979) 1.02
Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol (1983) 1.01
Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement. Br J Cancer (1987) 1.01
Clinical profiles of hospital discharge rates in local communities. Health Serv Res (1985) 1.01
Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. Eur J Cancer (1968) 1.00
Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma. Cancer Treat Rep (1985) 0.99
Radiotherapy for stage I seminoma testis: results of treatment and complications. Radiother Oncol (1986) 0.99
Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy. Cancer (1976) 0.98
A human testicular teratoma serially transplanted in immune-deprived mice. Br J Cancer (1979) 0.97
Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis. Radiother Oncol (1987) 0.97
A comparison of the chemosensitivity of a primary tumour and its metastases using a human tumour xenograft. Eur J Cancer (1979) 0.97
Alcohol pain in Hodgkin's disease. Cancer (1976) 0.97
Serum-alpha1-fetoprotein in patients with testicular tumours. Lancet (1976) 0.97
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol (1991) 0.97
Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour. Br J Cancer (1979) 0.96
Hospital use by the aging population. Inquiry (1981) 0.96
Axis induction by wnt signaling: Target promoter responsiveness regulates competence. Dev Biol (2001) 0.96
Bilateral germ cell tumours of the testis. Br J Urol (1980) 0.96
Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly. Gut (1993) 0.95
Criteria for a proof of migration routes of immature parasites inside hosts exemplified by studies of Strongyloides ratti in the rat. Parasitology (1988) 0.94
The role of ultrasound in the assessment and treatment of abdominal metastases from testicular tumours. Clin Radiol (1977) 0.94
Orchidectomy alone for stage I seminoma of the testis. Cancer (1990) 0.93
In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids. Br J Cancer (1982) 0.92
The role of surgery in the combined management of metastases from malignant teratomas of testis. Br J Urol (1987) 0.92
Postchemotherapy staging laparotomy in Hodgkin's disease. Br J Cancer (1982) 0.92
Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol (1993) 0.91
Oral contraceptives and breast cancer. Br J Cancer (1990) 0.91
Lung damage in C57B1 mice following thoracic irradiation: enhancement by chemotherapy. Br J Radiol (1979) 0.90
Experimental combination and single-agent chemotherapy in human lung-tumour xenografts. Br J Cancer (1982) 0.90
Failure of methyl-C.C.N.U. and 5-fluorouracil in colorectal cancer. Lancet (1978) 0.90
Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen. Cancer Res (1986) 0.89
Elective delayed excision of bulky para-aortic lymph node metastases in advanced non-seminoma germ cell tumours of testis. Br J Urol (1981) 0.89
Extranodal non-Hodgkin's lymphoma presenting in the testicle: a clinical and pathologic study of 24 cases. Cancer (1980) 0.89
A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069. Br J Radiol (1986) 0.89
Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. Br J Cancer (1976) 0.88
Elevated serum alphafetoprotein and seminoma: clinical evidence for a histologic continuum? Cancer (1982) 0.88
Expanding the role of social workers in coordination of health services. Health Soc Work (1981) 0.87